AstraZeneca booster generates higher antibodies against Omicron: New data

Must read

What Is XClass TV?

Comcast Comcast wants to take on the likes of Roku, Fire TV, and Android TV with its XClass TV platform. But what does it...

Autel Evo Lite+ review | TechRadar

Two-minute reviewIn August 2021, Autel threw DJI something of a curveball when it announced four new drones in two new series: the Evo...

Minecraft shaders [January 2022]: Best shaders packs for Minecraft, how to install them

Minecraft has a signature look with square lo-fi character models, trees, clouds, and more as the world is made of blocks. If you...
Bhawani Singhhttps://techmepro.com
I am a blogger who believes in delivering latest tech news from around the world to my viewers.

AstraZeneca said on Thursday preliminary data from a trial it conducted on its COVID-19 shot, Vaxzevria, showed it generated a higher antibody response against the Omicron variant and others, including Beta, Delta, Alpha and Gamma, when given as a third booster dose.

The increased response was seen in people who were previously vaccinated with either Vaxzevria or an mRNA vaccine, the drugmaker said, adding that it would submit this data to regulators worldwide given the urgent need for boosters.


AstraZeneca has developed the vaccine with researchers from the University of Oxford, and lab studies last month found a three-dose course of Vaxzevria was effective against the rapidly spreading new variant.

The data is the first released by the company from its trials into boosters of its vaccine.

The company said it adds to the growing evidence that supports a third dose of its vaccine irrespective of the primary vaccination schedule.


“These important studies show that a third dose of Vaxzevria after two initial doses of the same vaccine, or after mRNA or inactivated vaccines, strongly boosts immunity against COVID-19,” Oxford Vaccine Group chief Andrew Pollard said in a statement.

A major British trial in December found that AstraZeneca’s shot increased antibodies when given as a booster after initial vaccination with its own shot or Pfizer’s, which is based on mRNA technology.

However, the study concluded that mRNA vaccines made by Pfizer and Moderna gave the biggest boost to antibodies when given as a booster dose.

 

(Reporting by Pushkala Aripaka in Bengaluru; editing by Subhranshu Sahu and Jason Neely)

Subscribe to Mint Newsletters

* Enter a valid email

* Thank you for subscribing to our newsletter.

Never miss a story! Stay connected and informed with Mint.
Download
our App Now!!

Source link

More articles

Leave a Reply

Subscribe to our newsletter

To be updated with all the latest news, offers and special announcements.

- Advertisement -

Latest article

OnePlus Nord Series Phone Priced Under Rs. 20,000 Tipped to Launch in India in Q3: Leaked Specifications

OnePlus is said to be working on a new smartphone for India in the sub-Rs. 20,000 segment. The Chinese smartphone company that recently...

Wordle: How to Block Scores From Your Twitter Feed

Wordle — the daily secret word game — has taken social media by storm recently. With its little green, yellow, and grey-coloured...

Halo Capsule review | TechRadar

One-minute reviewHalo is a small brand with big ambition, but it’s a relative newcomer to the floorcare market, so might not be on...

Realme 9 Pro+ Launch Confirmed by Company; Specifications, Renders Surface Online

Realme 9 Pro+ launch has been teased by the Chinese company. The new model is expected to come alongside the regular Realme 9...

Google might bring Material You to Chrome OS soon

Dynamic colors, rounded corners, and everything else; as you know it ...
- Advertisement -